Pluronic® P123/F127 mixed micelles delivering sorafenib and its combination with verteporfin in cancer cells

Código QR

Pluronic® P123/F127 mixed micelles delivering sorafenib and its combination with verteporfin in cancer cells

Diogo Silva Pellosi,1,2,* Francesca Moret,3,* Aurore Fraix,4 Nino Marino,4 Sara Maiolino,2 Elisa Gaio,3 Noboru Hioka,1 Elena Reddi,3 Salvatore Sortino,4 Fabiana Quaglia2 1Research Nucleus of Photodynamic Therapy, Chemistry Department, State University of Maringá, Maringá, Braz...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Pellosi DS, Moret F, Fraix A, Marino N, Maiolino S, Gaio E, Hioka N, Reddi E, Sortino S, Quaglia F
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	Pluronic Micelles Sorafenib Chemotherapy Photodynamic Therapy Verteporfin Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/b77f3e1332d44c15b968dc0b119757cd
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Long-term outcomes in half-dose verteporfin photodynamic therapy for chronic central serous retinopathy
por: Dhirani NA, et al.
Publicado: (2017)

Redox-sensitive Pluronic F127-tocopherol micelles: synthesis, characterization, and cytotoxicity evaluation
por: Liu Y, et al.
Publicado: (2017)

SOLUBILIZATION OF P-ALKYLPHENOLS IN PLURONICS F-68 AND F-127 MICELLES: PARTITION COEFFICIENTS AND EFFECT OF SOLUTE ON THE AGGREGATE STRUCTURE
por: ANDRÉS F.,OLEA, et al.
Publicado: (2014)

Folic acid-functionalized drug delivery platform of resveratrol based on Pluronic 127/D-α-tocopheryl polyethylene glycol 1000 succinate mixed micelles
por: Hao J, et al.
Publicado: (2017)

Enhancing the oral bioavailability of biochanin A by encapsulation in mixed micelles containing Pluronic F127 and Plasdone S630
por: Wu X, et al.
Publicado: (2017)

Verteporfin-Loaded Anisotropic Poly(Beta-Amino Ester)-Based Micelles Demonstrate Brain Cancer-Selective Cytotoxicity and Enhanced Pharmacokinetics
por: Shamul JG, et al.
Publicado: (2019)

Efficacy and safety of ranibizumab monotherapy versus ranibizumab in combination with verteporfin photodynamic therapy in patients with polypoidal choroidal vasculopathy: 12-month outcomes in the Japanese cohort of EVEREST II study
por: Takahashi K, et al.
Publicado: (2018)

c(RGDyK)-decorated Pluronic micelles for enhanced doxorubicin and paclitaxel delivery to brain glioma
por: Huang YK, et al.
Publicado: (2016)

Synthesis, Characterization, and Toxicity Assessment of Pluronic F127-Functionalized Graphene Oxide on the Embryonic Development of Zebrafish (Danio rerio)
por: Shamsi S, et al.
Publicado: (2020)

Development and characterization of self-assembling lecithin-based mixed polymeric micelles containing quercetin in cancer treatment and an in vivo pharmacokinetic study
por: Chen LC, et al.
Publicado: (2016)

Sorafenib induced acral pigmentation: A new entity
por: Mrinal Gupta, et al.
Publicado: (2015)

Berberine-Loaded Thiolated Pluronic F127 Polymeric Micelles for Improving Skin Permeation and Retention
por: Niu J, et al.
Publicado: (2020)

Prediction of early recurrence and response to adjuvant Sorafenib for hepatocellular carcinoma after resection
por: Liming Zheng, et al.
Publicado: (2021)

The Influence of Tea Tree Oil on Antifungal Activity and Pharmaceutical Characteristics of Pluronic<sup>®</sup> F-127 Gel Formulations with Ketoconazole
por: Magdalena Wróblewska, et al.
Publicado: (2021)

Ranibizumab in monotherapy and combined with photodynamic therapy for retinal angiomatous proliferation
por: Arias L, et al.
Publicado: (2016)

Honokiol/Magnolol-Loaded Self-Assembling Lecithin-Based Mixed Polymeric Micelles (lbMPMs) for Improving Solubility to Enhance Oral Bioavailability
por: Lin HL, et al.
Publicado: (2021)

Tolerability of oral sorafenib in pet dogs with a diagnosis of cancer
por: Foskett A, et al.
Publicado: (2017)

Acne Inversa-like Lesions Induced by a Low Dose of Sorafenib
por: Javier Aubán-Pariente, et al.
Publicado: (2021)

X-ray radiation-induced and targeted photodynamic therapy with folic acid-conjugated biodegradable nanoconstructs
por: Clement S, et al.
Publicado: (2018)

Polymeric micelles for potentiated antiulcer and anticancer activities of naringin
por: Mohamed EA, et al.
Publicado: (2018)

Vitamin E succinate-conjugated F68 micelles for mitoxantrone delivery in enhancing anticancer activity
por: Liu Y, et al.
Publicado: (2016)

Guiding Appropriate Timing of Laser Irradiation by Polymeric Micelles for Maximizing Chemo-Photodynamic Therapy
por: Zhu Y, et al.
Publicado: (2020)

Redox-responsive F127-folate/F127-disulfide bond-D-α-tocopheryl polyethylene glycol 1000 succinate/P123 mixed micelles loaded with paclitaxel for the reversal of multidrug resistance in tumors
por: Lin J, et al.
Publicado: (2018)

Redox-sensitive micelles composed of disulfide-linked Pluronic-linoleic acid for enhanced anticancer efficiency of brusatol
por: Zhang J, et al.
Publicado: (2018)

Design And Characterisation Of Novel Sorafenib-Loaded Carbon Nanotubes With Distinct Tumour-Suppressive Activity In Hepatocellular Carcinoma
por: Elsayed MMA, et al.
Publicado: (2019)

Sorafenib-Loaded Nanoparticles Based on Biodegradable Dendritic Polymers for Enhanced Therapy of Hepatocellular Carcinoma
por: Li Z, et al.
Publicado: (2020)

Antibiotic Therapy is Associated with Worse Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib
por: Pomej K, et al.
Publicado: (2021)

A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer
por: Archibald M, et al.
Publicado: (2016)

Outstanding Response to Sorafenib in a Patient with Metastatic Gastrointestinal Stromal Tumour
por: Charlotte Brinch, et al.
Publicado: (2021)

Formulation and evaluation of mixed polymeric micelles of quercetin for treatment of breast, ovarian, and multidrug resistant cancers
por: Patra A, et al.
Publicado: (2018)

In vivo biodistribution, biocompatibility, and efficacy of sorafenib-loaded lipid-based nanosuspensions evaluated experimentally in cancer
por: Yang S, et al.
Publicado: (2016)

Cyclic RGD-conjugated Pluronic® blending system for active, targeted drug delivery
por: Lim C, et al.
Publicado: (2018)

MiRNA-200b reverses drug resistance of hepatocellular carcinoma HepG2 cells to sorafenib and its underlying mechanism
por: DENG Yong, et al.
Publicado: (2021)

Baicalin Enhanced Oral Bioavailability of Sorafenib in Rats by Inducing Intestine Absorption
por: Jingyao Wei, et al.
Publicado: (2021)

Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects
por: Ilaria Romito, et al.
Publicado: (2021)

AlPcS4-PDT for gastric cancer therapy using gold nanorod, cationic liposome, and Pluronic® F127 nanomicellar drug carriers
por: Xin J, et al.
Publicado: (2018)

Transferrin receptor-targeted HMSN for sorafenib delivery in refractory differentiated thyroid cancer therapy
por: Ke Y, et al.
Publicado: (2018)

Autophagy-Related Chemoprotection against Sorafenib in Human Hepatocarcinoma: Role of FOXO3 Upregulation and Modulation by Regorafenib
por: Flavia Fondevila, et al.
Publicado: (2021)

Co-Administration of iRGD with Sorafenib-Loaded Iron-Based Metal-Organic Framework as a Targeted Ferroptosis Agent for Liver Cancer Therapy
por: Liu X, et al.
Publicado: (2021)

ABCC5 facilitates the acquired resistance of sorafenib through the inhibition of SLC7A11-induced ferroptosis in hepatocellular carcinoma
por: Wenbin Huang, et al.
Publicado: (2021)